<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> (LAC) are antibodies which are detected by a prolongation of <z:chebi fb="0" ids="16247">phospholipid</z:chebi>-dependent coagulation assays, and are associated with thrombotic events and <z:e sem="disease" ids="C0032962" disease_type="Disease or Syndrome" abbrv="">pregnancy complications</z:e> in patients with the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> is defined by arterial or <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> and/or pregnancy morbidity and by laboratory diagnosis of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The laboratory diagnosis is based on LAC and/or anticardiolipin and/or anti-beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I antibodies present in plasma, on two or more occasions at least 12 weeks apart </plain></SENT>
<SENT sid="3" pm="."><plain>ALthough the presence of LAC correlates best with <z:mp ids='MP_0005048'>thrombosis</z:mp>, the Laboratory testing of LAC is not well standardized </plain></SENT>
<SENT sid="4" pm="."><plain>In this article, the Laboratory evaluation of LAC will be explained, including the different tests that are recommended by the Israeli Sub-committee of <z:mp ids='MP_0005048'>Thrombosis</z:mp> and Hemostasis Laboratories, the possibility to evaluate LAC in patients treated with antithrombotic therapy, and how to report and interpret the results </plain></SENT>
</text></document>